Lilly posts 45% sales jump, culls four programs across obesity, Alzheimer's, heart failure and eczema

Eli Lilly said Thursday that its fourth-quarter revenue jumped 45% to $13.53 billion over the prior year, though this fell short of earlier projections. The drugmaker also reiterated the $58 billion to $61 billion in ...